These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 6805532

  • 21. DDAVP in haemophilia and von Willebrand's disease.
    Lancet; 1983 Oct 01; 2(8353):774-5. PubMed ID: 6137606
    [No Abstract] [Full Text] [Related]

  • 22. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L, Boggio L, Green D.
    Curr Hematol Rep; 2005 Jan 01; 4(1):1-2. PubMed ID: 15610653
    [No Abstract] [Full Text] [Related]

  • 23. IIB von Willebrand's disease: pathogenetic and therapeutic studies.
    Kyrle PA, Niessner H, Dent J, Panzer S, Brenner B, Zimmerman TS, Lechner K.
    Br J Haematol; 1988 May 01; 69(1):55-9. PubMed ID: 3132965
    [Abstract] [Full Text] [Related]

  • 24. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
    Theiss W, Schmidt G.
    Thromb Res; 1978 Dec 01; 13(6):1119-23. PubMed ID: 311959
    [No Abstract] [Full Text] [Related]

  • 25. The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease.
    McCarroll DR, Ruggeri ZM, Montgomery RR.
    Blood; 1984 Mar 01; 63(3):532-5. PubMed ID: 6607754
    [Abstract] [Full Text] [Related]

  • 26. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
    Schmitz-Huebner U, Balleisen L, Arends P, Pollmann H, Sutor AH.
    Haemostasis; 1980 Mar 01; 9(4):204-13. PubMed ID: 6772527
    [Abstract] [Full Text] [Related]

  • 27. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H, Takase T.
    Rinsho Ketsueki; 1985 Jul 01; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract] [Full Text] [Related]

  • 28. Acquired von Willebrand's disease in the myeloproliferative syndrome.
    Budde U, Schaefer G, Mueller N, Egli H, Dent J, Ruggeri Z, Zimmerman T.
    Blood; 1984 Nov 01; 64(5):981-5. PubMed ID: 6333259
    [Abstract] [Full Text] [Related]

  • 29. Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor.
    Rodeghiero F, Castaman G, Di Bona E, Ruggeri M, Lombardi R, Mannucci PM.
    Eur J Haematol; 1988 Feb 01; 40(2):163-7. PubMed ID: 3126081
    [Abstract] [Full Text] [Related]

  • 30. The role of the spleen in regulating the plasma levels of factor VIII--von Willebrand's factor after DDAVP.
    Garcia VV, Coppola R, Mannucci PM.
    Blood; 1982 Dec 01; 60(6):1402-6. PubMed ID: 6814552
    [Abstract] [Full Text] [Related]

  • 31. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
    Takase T, Nishino M, Yasui M, Shima M, Yoshikawa N, Fukui H.
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov 01; 48(7):1571-8. PubMed ID: 3937410
    [No Abstract] [Full Text] [Related]

  • 32. The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors.
    Batlle J, Lopez Fernandez MF, Campos M, Justica B, Berges C, Navarro JL, Diaz Cremades JM, Kasper CK, Dent JA, Ruggeri ZM.
    Blood; 1986 Dec 01; 68(6):1207-12. PubMed ID: 3490883
    [Abstract] [Full Text] [Related]

  • 33. Effect of desmopressin acetate on bleeding times and plasma von Willebrand factor in Doberman pinscher dogs with von Willebrand's disease.
    Kraus KH, Turrentine MA, Jergens AE, Johnson GS.
    Vet Surg; 1989 Dec 01; 18(2):103-9. PubMed ID: 2786279
    [Abstract] [Full Text] [Related]

  • 34. [Willebrand's disease and multimeric analysis of the Willebrand factor].
    Hauert J, Tran-Thang C, Bachmann F.
    Schweiz Med Wochenschr; 1985 Dec 07; 115(49):1773-5. PubMed ID: 3879003
    [Abstract] [Full Text] [Related]

  • 35. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A.
    Haematologia (Budap); 1994 Dec 07; 26(2):97-109. PubMed ID: 7890268
    [Abstract] [Full Text] [Related]

  • 36. [Response to DDAVP in von Willebrand disease type II C].
    Batllé Fonrodona J, López Fernández MF, Martín González R, Fernández Villamor A, López Borrasca A, Lasierra Cirujeda J.
    Sangre (Barc); 1985 Dec 07; 30(2):181-4. PubMed ID: 3925573
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
    Mariana G, Ciavarella N, Mazzucconi MG, Antoncecchi S, Solinas S, Ranieri P, Pettini P, Agrestini F, Mandelli F.
    Clin Lab Haematol; 1984 Dec 07; 6(3):229-38. PubMed ID: 6440729
    [Abstract] [Full Text] [Related]

  • 38. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
    Casonato A, Sartori MT, Pontara E, Bertomoro A, Dannhäuser D, Girolami.
    Blood Coagul Fibrinolysis; 1991 Aug 07; 2(4):567-73. PubMed ID: 1768767
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).
    Ruggeri ZM, Nilsson IM, Lombardi R, Holmberg L, Zimmerman TS.
    J Clin Invest; 1982 Nov 07; 70(5):1124-7. PubMed ID: 6982283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.